Bank of Montreal Can Cuts Stake in SPDR S&P Biotech ETF $XBI

Bank of Montreal Can reduced its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 140,558 shares of the exchange traded fund’s stock after selling 14,867 shares during the period. Bank of Montreal Can owned about 0.26% of SPDR S&P Biotech ETF worth $11,657,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. DHJJ Financial Advisors Ltd. bought a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at $25,000. Garrison Bradford & Associates Inc. purchased a new stake in SPDR S&P Biotech ETF during the first quarter valued at about $39,000. Quaker Wealth Management LLC grew its stake in shares of SPDR S&P Biotech ETF by 101.2% during the second quarter. Quaker Wealth Management LLC now owns 623 shares of the exchange traded fund’s stock valued at $52,000 after buying an additional 53,536 shares during the last quarter. Avalon Trust Co purchased a new position in shares of SPDR S&P Biotech ETF in the first quarter worth about $57,000. Finally, Curio Wealth LLC increased its holdings in shares of SPDR S&P Biotech ETF by 74,700.0% in the second quarter. Curio Wealth LLC now owns 748 shares of the exchange traded fund’s stock worth $62,000 after buying an additional 747 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $108.96 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $113.21. The stock has a 50 day moving average price of $102.21 and a two-hundred day moving average price of $90.42. The company has a market capitalization of $6.61 billion, a P/E ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.